Naslund Medical Inc.

Naslund Medical Inc. manufactures the Gold Anchor, an innovative fiducial marker device designed for precision radiotherapy and surgical guidance. The Gold Anchor is a minimally invasive, gold-based fiducial marker that enables accurate tumor localization and tracking across multiple imaging modalities including kV, CT, and MR. Invented by Dr. Ingemar Naslund, an Associate Professor and head of the Division of Radiation Therapy at Karolinska University Hospital in Stockholm, the device features industry-leading thin needles for minimal invasiveness, excellent visibility across imaging platforms, and instant stability through multiple cut-outs allowing controlled marker folding. The Gold Anchor supports advanced radiotherapy techniques including stereotactic body radiation therapy (SBRT), real-time tumor tracking, particle therapy, and intrafraction motion management. Applications span breast radiation therapy and biopsy marking, lung radiotherapy and surgery, abdominal, gynecologic, prostate, and endoscopic procedures. The device is compatible with leading radiotherapy systems from Varian, Elekta, Accuray, and Brainlab, making it essential for precision oncology and surgical targeting.